In 1995, Johns Hopkins launched a new method of delivering care to blood and bone marrow transplant (BMT) patients and their families.
IPOP is a patient-focused delivery model that:
- maximizes opportunities in the ambulatory setting
- minimizes the need for inpatient care
- ensures continuity of providers across the care continuum
This novel approach includes intensive ambulatory support adjacent to the inpatient units, 24-hour access to care and residential living facilities. Patients come to the IPOP clinic each day for care and spend their nights in residential living facilities or in their own homes with their caregiver.
Complications such as fevers, organ dysfunction and graft-versus-host disease dictate changes in the location of care from the IPOP clinic to the inpatient unit. As patients recover, they move back to the clinic. The same primary medical and nursing teams care for patients whether they are on the BMT unit or in the IPOP clinic.
As a result of making these changes in our BMT program, our IPOP patients spend less than 10 days of their total stay in an inpatient bed. Patients and families benefit from the opportunity to remain an outpatient for much of their stay and appreciate the enhanced continuity of care.